|
RNA Atrium Therapeutics Inc 2093101 |
| Balance Sheet |
|
Current Assets
|
$275,051,000.00 |
|
Assets
|
$280,512,000.00 |
|
Current Liabilities
|
$31,508,000.00 |
|
Liabilities
|
$65,936,000.00 |
|
Equity
|
$214,576,000.00 |
|
Shares Out
|
17106000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-35,069,000.00 |
|
Investing Cash Flow
|
$-193,685,000.00 |
| Market Analysis |
Market Cap
|
$230,588,880.00 |
|
Price
|
$13.48 |
|
BVPS
|
12.54 |
|
PB
|
1.08 |
|
EPS
|
-1.18 |
|
PS
|
19.19 |
|
FCF
|
$-37,203,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:37 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-4.97 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.21 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-1.27 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RNA documents filed with the SEC.
RNA Filings
Clear
